FocusCancer

Cholesterol, cancer, and rebooting a treatment for athlete’s foot

See allHide authors and affiliations

Science Translational Medicine  18 Apr 2018:
Vol. 10, Issue 437, eaat3741
DOI: 10.1126/scitranslmed.aat3741

You are currently viewing the abstract.

View Full Text

Log in to view the full text

Log in through your institution

Log in through your institution

Abstract

A key enzyme in cholesterol synthesis is placed firmly on the oncogenic map and demonstrated to be a potential therapeutic target in liver cancer by repurposing a common antifungal agent (Liu et al., this issue).

View Full Text